Leucine describes itself as “a digital twin of the pharma manufacturing shop floor.” It enables real-time performance monitoring and compliance management, analyzes the root cause of ...

So far, Leucine has signed up around 35 pharma companies to its platform; collectively, these customers are using the system in around 300 facilities in 10 countries, twice as many as a year ago.

Leucine largely competes with global players in the healthtech SaaS segment. However, the startup’s niche lies with the global pharma 4.0 space, which is projected to become a $63.17 Bn market ...